Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy

Abnormal metabolism is another cancer hallmark. The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy. Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; neve...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Cervantes-Madrid, Diana, Romero, Yair, Dueñas-González, Alfonso
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2015
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575731/
https://ncbi.nlm.nih.gov/pubmed/26425550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/690492
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky